ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC

ClinicalTrials.gov ID: NCT03077243

Public ClinicalTrials.gov record NCT03077243. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

LCCC 1612: P53 Mutational Status and Circulating Free HPV DNA for the Management of HPV-associated Oropharyngeal Squamous Cell Cancers

Study identification

NCT ID
NCT03077243
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Other
Enrollment
195 participants

Conditions and interventions

Interventions

  • Assessment for surgical evaluation Procedure
  • Cisplatin (or alternative) Drug
  • Intensity Modulated Radiotherapy (IMRT) Radiation

Procedure · Drug · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2016
Primary completion
Dec 13, 2022
Completion
Dec 13, 2022
Last update posted
May 1, 2024

2016 – 2022

United States locations

U.S. sites
4
U.S. states
2
U.S. cities
4
Facility City State ZIP Site status
University of Florida Gainesville Florida 32610
University of Florida Proton Therapy Institute Jacksonville Florida 32206
University of North Carolina at Chapel Hill, Department of Radiation Oncology Chapel Hill North Carolina 27599
Rex Healthcare Raleigh North Carolina 27607

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03077243, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 1, 2024 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03077243 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →